Transforming The Future Of Cancer Therapy.

Shaping A New Era Of Immunotherapy

Traditionally, cancer vaccines have mainly focused on identifying the subtle differences present in the tumor microenvironment and aimed to create a simple building block that can be used as a vaccine entity. However, the actual drug delivery and stability in the body have largely been ignored leading to limited success in the clinic.

The Technology

Recent News

Mårten Winge new CEO

STRIKE Pharma appoints industry veteran Mårten Winge as new CEO

Strike raises SEK 10M (>1M $)

Swedish immuno-oncology newcomer STRIKE Pharma raises SEK 10 million for development of individualized solid tumour therapy.